Recent Price Movement and Market Context
On 8 December 2025, Entero Healthcare Solutions recorded its lowest price in the past year at Rs.1015. This level represents a notable drop from its 52-week high of Rs.1564.95. Over the last three trading sessions, the stock has registered a cumulative return of -2.8%, underperforming its retailing sector peers by approximately 1.04% on the day of the new low.
The stock is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating a sustained downward trend in price momentum. This contrasts with the broader market benchmark, the Sensex, which despite a negative session, remains near its 52-week high and trades above its 50-day and 200-day moving averages.
Comparative Performance Over One Year
Entero Healthcare Solutions’ one-year performance shows a decline of 30.34%, a stark contrast to the Sensex’s gain of 4.51% over the same period. This divergence highlights the stock’s relative weakness within the retailing sector and the broader market. Additionally, the stock has underperformed the BSE500 index across multiple time frames, including the last three years, one year, and three months, reflecting persistent challenges in maintaining price stability.
Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!
- - Current monthly selection
- - Single best opportunity
- - Elite universe pick
Financial Metrics and Operational Highlights
Despite the stock’s price decline, Entero Healthcare Solutions has demonstrated several positive financial indicators. The company’s net sales have grown at an annual rate of 30.10%, with operating profit expanding at a rate of 127.38%. The most recent quarterly results show net sales reaching Rs.1,570.95 crore, the highest recorded, alongside a PBDIT of Rs.62.06 crore and an operating profit margin of 3.95% relative to net sales.
These figures indicate consistent revenue growth and profitability over recent quarters, with the company reporting positive results for seven consecutive quarters. The return on capital employed (ROCE) stands at 8.6%, supported by an enterprise value to capital employed ratio of 2.3, suggesting a valuation that is attractive relative to capital utilisation.
Debt and Institutional Holdings
Entero Healthcare Solutions maintains a low debt burden, with a Debt to EBITDA ratio of 1.33 times, reflecting a strong capacity to service its obligations. Institutional investors hold 24.32% of the company’s shares, indicating a significant stake by entities with extensive resources and analytical capabilities.
Valuation and Market Position
The stock is currently trading at a discount compared to the average historical valuations of its peers in the retailing sector. Over the past year, while the stock price has declined by over 30%, the company’s profits have risen by 142%, resulting in a price-to-earnings-to-growth (PEG) ratio of 0.3. This disparity between earnings growth and stock price performance reflects a complex market assessment of the company’s prospects.
Entero Healthcare Solutions or something better? Our SwitchER feature analyzes this small-cap Retailing stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Sector and Market Environment
The retailing sector, in which Entero Healthcare Solutions operates, has faced mixed conditions in recent months. On the day the stock hit its 52-week low, the Sensex opened flat but later declined by 242.55 points, or 0.39%, closing at 85,382.29. Despite this, the Sensex remains within 1% of its 52-week high, supported by bullish moving averages. This divergence between the broader market and Entero Healthcare Solutions’ stock price highlights sector-specific pressures and company-level factors influencing investor sentiment.
Summary of Price and Performance Indicators
To summarise, Entero Healthcare Solutions’ stock price has reached Rs.1015, its lowest level in the past year, following a three-day decline and underperformance relative to its sector. The stock’s position below all major moving averages signals continued downward momentum. Over the last year, the stock’s return contrasts with the broader market’s positive performance, despite the company’s growth in sales and profits.
While the company’s financial fundamentals show strength in revenue growth, profitability, and debt management, the market valuation and price action reflect a cautious stance. Institutional holdings remain significant, suggesting ongoing interest from well-resourced investors.
Limited Time Only! Upgrade now and get 1 Year of Stock of the week worth Rs. 14,999 for FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
